NCT00005872 Nitrocamptothecin in Treating Patients With Recurrent Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00005868 Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00005865 Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00005858 LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer Status COMPLETED Phase PHASE1
NCT00005850 Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00005849 Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00005825 Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer Status UNKNOWN Phase PHASE2
NCT00005806 Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT00005646 Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00005630 Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT00005590 Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma Status COMPLETED Phase PHASE3
NCT00005093 Gemcitabine With or Without CI-994 in Treating Patients With Advanced Non-small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT00005091 DX-8951f in Treating Previously Untreated Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00005071 Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer Status UNKNOWN Phase NA
NCT00005062 Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission Status COMPLETED Phase PHASE3
NCT00005059 Carboplatin and Paclitaxel in Treating Older Patients With Metastatic or Recurrent Unresectable Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00005055 Glufosfamide With of Without Hydration in Treating Patients With Advanced Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00005041 R115777 in Treating Patients With Relapsed Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00005037 Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00005032 Bcl-2 Antisense Oligodeoxynucleotide G3139 and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer Status COMPLETED Phase PHASE1/PHASE2